There is no single “best” pain medication for severe arthritis because the right choice depends on which type of arthritis you have, how many joints are affected, and your overall health. Osteoarthritis and rheumatoid arthritis are treated with fundamentally different drug strategies, and what works well for one can be useless or even harmful for the other. The most effective options range from NSAIDs for osteoarthritis to biologic therapies for inflammatory types like rheumatoid arthritis, with several important layers in between.
Osteoarthritis vs. Rheumatoid Arthritis: Why It Matters
Osteoarthritis is a wear-and-tear condition where cartilage breaks down over time. The pain comes from bone rubbing on bone, inflammation in the joint lining, and stiffening of surrounding tissue. Medications for OA focus almost entirely on controlling pain and inflammation because no drug has been shown to reverse or slow the cartilage damage itself. Disease-modifying drugs, which work well in rheumatoid arthritis, have been tested repeatedly in osteoarthritis and failed. Major guidelines now strongly recommend against using them for OA.
Rheumatoid arthritis is an autoimmune disease where the immune system attacks the joint lining, causing progressive damage. Here, the goal isn’t just pain relief. It’s stopping the immune attack before it destroys the joint permanently. That makes the medication strategy completely different: the “best” drug is whatever controls the disease process, and pain relief follows from that.
NSAIDs: The Frontline for Osteoarthritis Pain
For osteoarthritis, oral and topical NSAIDs (like ibuprofen, naproxen, and diclofenac gel) remain the most widely recommended medications across all major treatment guidelines. Acetaminophen, once considered the default first choice, is no longer regarded as first-line therapy because its pain-relieving effect in OA is relatively weak compared to NSAIDs.
Topical NSAIDs are strongly recommended for knee osteoarthritis by every major guideline and are a good option for hand OA as well. They deliver the drug directly to the joint with far fewer systemic side effects than pills. However, topical formulations don’t work well for deep joints like the hip, where the medication can’t penetrate far enough through tissue to reach the inflammation.
For pain in multiple joints, or when topical options aren’t enough, oral NSAIDs are the next step. The CDC recommends using them at the lowest effective dose for the shortest time needed, particularly for older adults or people with heart or kidney problems. This isn’t just cautious language. A large meta-analysis found that users of certain NSAIDs had meaningfully higher cardiovascular risk: diclofenac raised the risk of major vascular events by about 37%, and ibuprofen nearly doubled the risk of major coronary events. Naproxen showed a more favorable cardiovascular profile, with no significant increase in vascular events overall, though all three common NSAIDs raised the risk of hospitalization for heart failure. Higher doses and longer-term use compound these risks.
Duloxetine: An Alternative When NSAIDs Fall Short
For people who can’t tolerate NSAIDs or don’t get enough relief from them, duloxetine is an option. It’s an antidepressant that also works on pain signaling pathways in the central nervous system. It’s approved for osteoarthritis pain in some countries, and the CDC specifically mentions it as a consideration for OA patients with pain in multiple joints. That said, all major guidelines give it only a conditional or weak recommendation, reflecting concerns about both its effectiveness and side effects like nausea, fatigue, and dizziness.
Cortisone Injections for Flare-Ups
When a single joint is severely inflamed, a cortisone injection directly into the joint can provide relief lasting up to several months. These injections work by delivering a powerful anti-inflammatory steroid right where it’s needed. They’re useful for managing flare-ups in both osteoarthritis and rheumatoid arthritis, but they’re not a long-term strategy. Doctors typically limit how many injections a joint receives per year because repeated shots may damage cartilage over time. The exact limit depends on the joint and the situation.
DMARDs and Biologics for Rheumatoid Arthritis
If you have rheumatoid arthritis, the most effective medications aren’t painkillers at all. They’re drugs that suppress the immune system’s attack on your joints. The standard starting treatment is methotrexate, taken once a week as a pill or injection. Doctors typically start at around 15 mg per week and increase by 5 mg per month up to 25 or 30 mg per week, depending on how you respond and what side effects you experience. If pills aren’t working well enough, switching to injections can improve absorption and effectiveness.
Methotrexate and similar conventional drugs have a slow onset. It can take several weeks to months before you feel a meaningful difference, which can be frustrating when you’re in severe pain. During that ramp-up period, NSAIDs or short courses of corticosteroids are often used to bridge the gap.
Taking methotrexate requires regular blood work to check your liver function, blood cell counts, and kidney function. Early on, blood tests are done monthly. Once you’re stable on the medication, testing shifts to every three or four months. Doctors watch for drops in white blood cells or platelets and for liver enzyme levels climbing above normal.
Biologics: When Standard Treatment Isn’t Enough
When methotrexate alone doesn’t control the disease, biologic therapies are the next level. These are engineered proteins, given by injection or infusion, that block specific molecules driving the immune attack. The main categories target different parts of the inflammatory chain.
TNF blockers were the first biologics developed for RA and remain widely used. They work by neutralizing a signaling protein called TNF-alpha that fuels joint inflammation. Most patients notice improvement within a few weeks, and some experience relief within days of the first dose, which is dramatically faster than conventional drugs.
For patients whose disease doesn’t respond to a TNF blocker, several other biologic options exist. Clinical trials comparing these second-line biologics in patients who failed TNF therapy found that rituximab (which depletes a type of immune cell called B cells) and tocilizumab (which blocks the inflammatory signal IL-6) consistently showed the strongest response rates. In one analysis, patients on rituximab were roughly 13 to 16 times more likely to achieve a major clinical response compared to placebo, and tocilizumab patients were about 10 to 12 times more likely.
A newer class of drugs called JAK inhibitors offers a pill-based alternative to injectable biologics. These work by blocking enzymes inside immune cells that relay inflammatory signals. They appeal to patients who prefer taking a daily pill over self-injecting, though they carry their own set of risks that require monitoring.
Where Opioids Fit (and Don’t)
Opioids are not recommended as routine therapy for arthritis pain. The CDC’s 2022 prescribing guideline is clear: nonopioid therapies are preferred for chronic pain, and evidence for opioids improving long-term pain or function in osteoarthritis is limited. Some evidence actually points to worse outcomes with prolonged opioid use for conditions like OA.
Tramadol, a weaker opioid, is acknowledged in some guidelines as a last resort when NSAIDs are contraindicated, not tolerated, or haven’t worked. But even this comes with the caveat that it should only be considered when no other viable options remain. The risks of dependence, tolerance, and side effects make opioids a poor long-term strategy for a condition that can last decades.
Choosing the Right Approach
For severe osteoarthritis, the most effective pharmacological path for most people starts with topical NSAIDs for accessible joints like the knee, moves to oral NSAIDs if needed (with careful attention to cardiovascular and gastrointestinal risk), and adds duloxetine or occasional cortisone injections when those aren’t sufficient. When medications stop providing adequate relief and joint damage is advanced, joint replacement surgery becomes the definitive treatment.
For severe rheumatoid arthritis, the goal is finding the right combination of disease-modifying therapy, often methotrexate plus a biologic, that puts the disease into remission or near-remission. When the immune attack is controlled, pain resolves as a consequence. The “best” medication in RA is whichever one successfully suppresses your specific disease activity, and finding that match sometimes takes trying more than one option.